Treatment of mediastinitis due to methicillin-resistant staphylococcus aureus in a renal dysfunction patient undergoing adjustments to the linezolid dose

Internal Medicine

Volumn 54, Issue 2, 2015, Pages 235-239

  Tsuji, Yasuhiro ^a   Tashiro, Masato ^a   Ashizawa, Nobuyuki ^a   Ota, Yukio ^a   Obi, Hayato ^b   Nagura, Saori ^b   Narukawa, Munetoshi ^a   Fukahara, Kazuaki ^b   Yoshimura, Naoki ^b   To, Hideto ^a   Yamamoto, Yoshihiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Linezolid; Mediastinitis; Methicillin resistant Staphylococcus aureus; Renal dysfunction; Therapeutic drug monitoring

Indexed keywords

C REACTIVE PROTEIN; CREATININE; LINEZOLID; SULTAMICILLIN; ACETAMIDE DERIVATIVE; OXAZOLIDINONE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MONITORING; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTOSIS; MALE; MEDIASTINITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; OFF PUMP CORONARY SURGERY; POSTOPERATIVE COMPLICATION; REMISSION; SEVERE RENAL IMPAIRMENT; STERNOTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; VACUUM ASSISTED CLOSURE; WOUND FLUID; ADVERSE EFFECTS; CHEMICALLY INDUCED; HEART SURGERY; MICROBIOLOGY; RENAL INSUFFICIENCY; STAPHYLOCOCCAL INFECTIONS;

ACETAMIDES; AGED; CARDIAC SURGICAL PROCEDURES; HUMANS; MALE; MEDIASTINITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY; STAPHYLOCOCCAL INFECTIONS; THROMBOCYTOPENIA;

EID: 84921280493     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.2292     Document Type: Article

References (19)

1. Farinas MC, Gald Peralta F, Bernal JM, Rabasa JM, Revuelta JM, Gonzalez-Macias J. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 20: 272-279, 1995.
2. Gardlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery: microbiology and pathogenesis. Eur J Cardiothorac Surg 21: 825-830, 2002.
3. Zurenko GE, Yagi BH, Schaadt RD, et al. In Vitro activities of U- 100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 40: 839-845, 1996.
4. Brier ME, Stalker DJ, Aronoff GR, et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob Agents Chemother 47: 2775-2780, 2003.
5. Sisson TL, Jungbluth GL, Hopkins NK. Age and sex effects on the pharmacokinetics of linezolid. Eur J Clin Pharmacol 57: 793-797, 2002.
6. Hiraki Y, Tsuji Y, Hiraike M, et al. Correlation between serum linezolid concentration and the development of thrombocytopenia. Scand J Infect Dis 44: 60-64, 2012.
7. Tsuji Y, Yukawa E, Hiraki Y, et al. Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction. J Clin Pharmacol 53: 967-973, 2013.
8. Wu VC, Wang YT, Wang CY, et al. High frequency of linezolidassociated thrombocytopenia and anemia among patients with endstage renal disease. Clin Infect Dis 42: 66-72, 2006.
9. Tsuji Y, Hiraki Y, Matsumoto K, et al. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction. J Infect Chemother 17: 70-75, 2011.
10. Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 34: 695-698, 2002.
11. Nukui Y, Hatakeyama S, Okamoto K, et al. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J Antimicrob Chemother 68: 2128-2133, 2013.
12. Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E, Furlanut M. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother 67: 2034-2042, 2012.
13. Majcher-Peszynska J, Haase G, Sass M, et al. Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections. Eur J Clin Pharmacol 64: 1093-1100, 2008.
14. Dodds Ashley ES, Carroll DN, Engemann JJ, et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 38: 1555-1560, 2004.
15. Sacar S, Sacar M, Aybek H, et al. Comparison of the therapeutic efficacy of linezolid and vancomycin and correlation of serum and tissue malondialdehyde and myeloperoxidase in an experimental mediastinitis model. J Surg Res 152: 89-95, 2009.
16. Tsuji Y, Hashimoto W, Taniguchi S, et al. Pharmacokinetics of linezolid in the mediastinum and pleural space. Int J Infect Dis 17: e1060-e1061, 2013.
17. Sasaki T, Takane H, Ogawa K, et al. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients. Antimicrob Agents Chemother 55: 1867-1873, 2011.
18. Kosaka T, Kokufu T, Shime N, et al. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients. Int J Antimicrob Agents 33: 368-370, 2009.
19. Cossu AP, Musu M, Mura P, De Giudici LM, Finco G. Linezolidinduced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature. Eur J Clin Pharmacol 70: 23-28, 2014.